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Baseanalogsarepowerfulantimetabolitesanddangerousmutagensgeneratedendogenouslybyoxidativestress,inﬂammation,and
aberrant nucleotide biosynthesis. Human inosine triphosphate pyrophosphatase (ITPA) hydrolyzes triphosphates of noncanonical
purine bases (i.e., ITP, dITP, XTP, dXTP, or their mimic: 6-hydroxyaminopurine (HAP) deoxynucleoside triphosphate) and thus
regulates nucleotide pools and protects cells from DNA damage. We demonstrate that the model purine base analog HAP induces
DNA breaks in human cells and leads to elevation of levels of ITPA. A human polymorphic allele of the ITPA, 94C->Ae n c o d e s
for the enzyme with a P32T amino-acid change and leads to accumulation of nonhydrolyzed ITP. The polymorphism has been
associated with adverse reaction to purine base-analog drugs. The level of both spontaneous and HAP-induced DNA breaks is
elevated in the cell line with the ITPA P32T variant. The results suggested that human ITPA plays a pivotal role in the protection
of DNA from noncanonical purine base analogs.
1.Introduction
Modiﬁed bases in DNA pose a severe threat for genome
integrity [1], (Figure 1). DNA could be directly damaged by
environmental factors such as ionizing radiation, chemical
mutagens or endogenous factors, such as oxidative stress
and inﬂammation [2–4]. Many of these factors also damage
nucleotides in DNA precursor pools [5–7]. Additionally,
cellular metabolism per se also contributes to the contam-
ination of pools by nucleobase-analogs. Base-analogs in
the deoxyribonucleoside triphosphate form are incorporated
into DNA by DNA polymerases and are the source of
genetic changes [8]. Potent repair systems remove not only
the lesions from DNA, but also the harmful triphosphates
from the DNA precursor pools (Figure 1,[ 1, 8]). Defects
of these protection mechanisms lead to hypermutagenesis
[9] or hyperrecombination [10–12] and result in genome
instability, which predisposes individuals to diseases like
cancer [13, 14]. Base-analogs are clinically important and
are widely used as immunosuppressants as well, antiviral
and anticancer agents. The determination of the reasons for
individual sensitivity/resistance is of high priority.
The major mutagenic modiﬁed purine bases include 8-
oxoguanine and 2-hydroxyadenine [15]. The 8-oxoguanine
in deoxyribonucleoside triphosphate form can be incor-
porated into DNA by replicative as well as specialized
DNA polymerases [16–18]. It can form base pairs with
cytosine and adenine and, therefore, can lead to transversion
mutations [19]. The MutT protein of E. coli hydrolyzes
8-oxodGTP to 8-oxodGMP, preventing incorporation into
DNA [17]. Mutational inactivation of this gene leads to
a 10.000-fold increase in the rates of transversions [20],
but no elevation of DNA fragmentation is detected in
mutT strains [21]. The 2-hydroxyadenine also has strong
mutagenic potential [3]. Deamination of normal purines,
as well as disregulation of the purine biosynthesis, leads
to contamination of nucleotide pools with deoxyinosine
triphosphate and deoxyxanthine triphosphate. Inﬂamma-
tion induces various types of base damage from oxidative
stress and elevated lipid peroxidation [22]. The latter can2 Journal of Nucleic Acids
generatemutagenicderivatives ofadenine andguanine, HAP
and its 2-amino derivative in vitro [23]. HAP might be
generated by monooxygenation of adenine [24]. HAP also
can be generated by adenylosuccinate synthase, an enzyme
of the de novo purine biosynthesis pathway wherein hydrox-
ylamine is provided instead of aspartate in the reaction with
IMP [25]. Thus, HAP can be a natural contaminant of
dNTP pools [23, 26], however the literature does not report
direct measurements of HAP derivatives in nucleotide pools.
HAP is strongly mutagenic in bacteria and yeast [26, 27].
The dHAPTP is incorporated into DNA by various DNA
polymerasesinvitro [28,29].Overwhelmingindirectgenetic
evidence in microorganisms suggests that the mutagenic
eﬀect is mediated by dHAPTP incorporation into DNA [26].
There is only fragmentary information about the eﬀects of
endogenous and exogenous base-analogs, such as HAP, in
multicellular eukaryotes.
There are a number of evolutionarily conserved enzy-
matic systems that sanitize the nucleotide pool by selectively
breaking deoxynucleoside triphosphate forms of base-analog
DNA precursors, either to monophosphate [17, 30]o rt o
nucleoside [31, 32] or diphosphate [33]. Additional systems
aﬀect quality of dNTP pools [34]. One of them, NUDT16,
destroys abnormal diphosphates [35]. Polymorphisms in the
genes encoding protective enzymes are associated with an
increasedriskofcancer[36],apredispositiontobase-analog-
associated adverse drug reactions [37] or a modulation of
response to therapy in hepatitis C patients [38].
ITPA is a prominent enzyme protecting from base-
analogs [27, 39]. ITPA orthologs from humans, yeast
(encoded by the HAM1 g e n e ) ,a n db a c t e r i a( e n c o d e db y
the rdgB gene) control levels of ITP, dITP and dHAPTP
by hydrolyzing ITP/dITP to PPi and IMP/dIMP [27, 30,
40]. One report documents that yeast ITPA can hydrolyze
pyrimidine analogs as well [41]. ITPA is highly conserved
among species [26, 40, 42]. In E. coli, the rdgB mutation
is synthetically lethal with the recA mutation abolishing
homologous recombination [27, 39]. The rdgB mutation
sensitizes to the mutagenic and recombinogenic eﬀects of
HAP in molybdenum-cofactor defective strain background
(another system protecting from HAP [43–45]) because of a
massive accumulation of breaks in DNA [27, 39, 46]. DNA
damage is caused by intermediates in the repair of base-
analogs in DNA by Endo V encoded by the nﬁ gene. This has
been proven by the viability of triple rdgB recA nﬁ mutants
[27].
HAP is very mutagenic in yeast but does not induce
recombination [48]. A defect in the yeast homolog of ITPA,
Ham1, leads to elevated HAPmutagenesis, but it does not
aﬀect spontaneous mutagenesis [49]. The natural substrate,
dITP, seems to be non-mutagenic when it is incorporated
in DNA, because hypoxanthine base pairs properly with
cytosine [50], and yeast apparently do not possess an enzyme
able to recognize hypoxanthine, xanthine and HAP in DNA
similar to Endo V. Therefore, DNA with these bases is
not nicked and no recombination and DNA breakage are
seen. The situation in yeast might be atypical. Inosine and
xanthine in DNA are recognized in most organisms by
a specialized repair system initiated by the orthologs of
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Figure 1: Base-analog DNA cycle. Environmental and intrinsic
mutagens can damage DNA directly or can damage DNA precursor
pools. When cleansing is ineﬃcient, base-analogs are incorporated
into DNA. Damaged bases lead to mutations in replication cycles or
can be correctly repaired by base excision repair. Intermediates of
this repair can lead to mutagenesis, DNA breaks, and chromosome
changes.
endonuclease V [51] and elicit DNA repair reactions that
leadtoDNAfragmentationandgenomicinstabilitywhenthe
l e v e lo fa n a l o g u e si sh i g h[ 3, 39, 46].
The repair of purine base-analogs in humans has not
been studied. Mutations in the human ITPA gene lead to
the accumulation of ITP in erythrocytes but do not show
a clear disease phenotype, perhaps due to compensation
by other cleansing enzymes [52, 53]. Human ITPA P32T
variant,abolishingtheITPAactivityinerythrocytes,hasbeen
associated in most publications with adverse reactions to
purine analogues used in the treatment of blood cancers,
transplant, and inﬂammatory bowel diseases [37, 54–59].
The ITPA P32T variant causes sensitivity to mercaptopurine
used for the treatment of acute lymphoblastic leukemia [60].
Knockout of the Itpa gene in mice is lethal primarily
because of heart failure [53]. Primary embryonic ﬁbroblasts
exhibit moderate chromosome instability phenotype [61],
and the inviability of the Itpa knockout mice suggests that
the enzyme performs essential functions in addition to the
prevention of the misincorporation of purine base-analogs
in DNA. If we assume that the role of ITPA is the same
in humans, the ITPA P32T variant should result in an
incomplete loss of activity, at least in the heart. Indeed, ITPA
with the change possesses enzymatic activity but is thermally
unstable[62,63],suggestingapossibilitythatthelevelsofthe
protein and its activity could vary among tissues.
In this study, we demonstrate by comet assay that
the model purine base-analog, HAP, induces DNA strand
breaks in three diﬀerent human cell lines. This suggests that
there is active recognition of incorporated base-analogs and
nicking of DNA. The inducibility of the system of HAP
repair was indicated by the shape of HAP dose response
on the frequency of DNA strand breaks. We suggest and
provide the evidence that one component of the repairJournal of Nucleic Acids 3
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Figure 2: Veriﬁcation of the genotype of the P32T cell line. Electropherogram of the DNA sequence of the region with C94A mutation is
shown. The experiment was performed as described in Section 2.
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(a) HPLC analysis of WI-38 extract.
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(b) HPLC analysis of P32T extract.
Figure 3: Accumulation of ITP in the P32T cell line. Areas of
chromatogram corresponding to ITP and IMP are enlarged in
boxes above the actual printout. Whole-cell lysates corresponding
to 100μg of protein were deproteinized by acid extraction with
1N HCl followed by alkali treatment with an equal volume of 1N
NaOH. The samples were centrifuged at 14,000RPM for 10min.
The volume of aqueous fraction (supernatant) was adjusted to
500uLwithHPLC-gradewater.ThesampleswererunonanAlltech
hypersil BDS C18 5u column. The HP 1100 HPLC connected to an
autosampler and a DAD detector (which was set at 262nm) was
used. Flow rate was kept constant at 1.1mL/min, and a gradient
ﬂow was used: 0 to 5 minutes, 100% (a). 5−5:10 ramp up to 100%
(b), 5:10−8:10, 100% (b), 8:10−8:20 ramp down to 100% (a). In
the preliminary experiments we have determined the retention of
pure 0.5mM solutions of ITP (∼2.6) and IMP (∼5.2).
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Figure 4: Speciﬁcity of polyclonal antibodies against ITPA in
Western blot. Western blots were performed as described in
Section 2. Antibodies against ITPA react largely with ITPA (a band
closer to 20kDa marker, see compared with lane where pure ITPA
was loaded, and predicted molecular mass was 21.4kDa) and, less
intense, with an unrelated protein running at 30kDa. The level of
ITPA, but not of this non-speciﬁc protein, is decreased almost 10-
fold in the soluble fraction of the P32T cell line. In the control
reprobing experiment the amount of GAPDH was the same in all
three cell lines (not shown). The position of the immunoreactive
bandwasshiftedup,closertothe30kDamarkerinthelanewiththe
6 His-tagged pure ITPA-P32T (predicted molecular mass 23.6kDa
[47]).Wealsoanalyzed theextractsof293celllinestransfectedwith
expressing ITPA-EGFP fusion protein (51.4kDa) and have found
that the major band was detected at a position corresponding to
50kD.
systemis ITPA.Consistent withthis,the levelofspontaneous
and base-analog-induced DNA damage was elevated in cell
line P32T with compromised ITPA activity. The levels and
distributionofITPAP32Tasdeterminedbyimmunostaining
have been changed in the P32T cell line. The results suggest
that patients with the 94C->A polymorphism in the ITPA4 Journal of Nucleic Acids
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Figure 5:HAPdoesnotinducemassivechromosomefragmentation.TheuntreatedHCT116metaphasespreads(a)andHCT116metaphase
spreads obtained at the end of treatment by 3.3mMHAP (b) were counterstained with DAPI (grey). Bar—10μm.
in addition to drug intolerance might possess increased
predisposition to diseases resulting from DNA repair defects.
2.MaterialsandMethods
2.1. Human Cell Cultures. The normal, diploid, human
lung ﬁbroblast cell line, WI-38, (ATCC CCL-75) was kindly
provided by Dr. Vera Gorbunova (University of Rochester,
NY). The human ﬁbroblast cell line (Coriell Institute
Biorepository (GMO1617), called here P32T, is homozygous
for a C>A transversion of nucleotide 94 (94C>A) in exon
2 of the ITPA gene. This leads to a proline to threonine
substitution at codon 32 (P32T). These untransformed cell
lines were cultivated as a monolayer in MEM (Invitrogen,
USA) supplemented with 10% fetal calf serum (GIBCO)
and 1mM sodium pyruvate (Invitrogen, USA) at 37◦Ci n
a5 %C O 2 atmosphere. For the ﬁbroblasts, cells at early
passages(<25passages)wereusedinallexperimentstoavoid
complications of replicative senescence because WI-38 cells
have a mean lifespan of approximately 45 to 60 population
doublings.
The epithelial colorectal cancer cell line HCT116 (ATCC,
CCL247, kindly provided by Dr. Robert E. Lewis, UNMC),
was cultivated in DMEM (Invitrogen, USA) containing 10%
fetal calf serum at 37◦Ci na5 %C O 2 atmosphere. The
colorectal cancer HCT116 cells are defective in mismatch
repair due to a nonsense mutation in the MLH1 gene
[64]. For the experiment addressing the speciﬁcity of our
antibodies against ITPA, we transfected colorectal carcinoma
293 cells by pEGFP plasmid (obtained from Dr. A. Rizzino,
UNMC) with ITPA cloned into BamH1-EcoRI sites in frame
with EGFP.
2.2.CharacterizationofP32TFibroblastCellLine. We veriﬁed
the presence of the 94C->A change in the ITPA gene by
sequencing of exon 2 ampliﬁed from genomic DNA (as exon
2−4 fragment) or from RNA. For genomic DNA isolation,
1×106 cells were harvested for ﬁbroblasts bearing wild-type
(WI-38) or mutant (P32T) ITPA, and DNA was isolated
according to the Fermentas Inc. protocol: (http://www.fer-
mentas.com/en/support/application-protocols). Brieﬂy, cell
pellets were lysed with SDS and Proteinase K. After incu-
bation with NaCl, DNA was phenol:chloroform extracted
and precipitated with ethanol. DNA pellets thus obtained
were resuspended in nuclease-free water. For RNA extraction
we have used the RNeasy kit (Qiagen, USA). The cDNA
synthesis was performed using the qScript DNA synthesis kit
(Quanta Biosciences #95047-025).
For ampliﬁcation of the speciﬁc ITPA region encompass-
ing the site of the 94C->A change, either genomic DNA or
cDNA was diluted 100-fold and exons 2 through 4 were
ampliﬁed using Exons 2, 3, 4 forward and reverse primers
and conditions [65]. Sequencing of the genomic fragment
was performed by the same primers and the sequence
of the cDNA fragment was performed using ITPA-sN
5 TCATTGGTGGGGAAGAAGATC and ITPA-sC 5 AAG-
CTGCCAAACTGCCAAA. The sequencing conﬁrmed that
the P32T cell line possesses 94C->A transversions (Figure 2).
We also detected the hallmark accumulation of ITP in
the P32T cell line by HPLC, conﬁrming that ITPA activity
is compromised in this cell line [65] (Figure 3).
2.3. The Alkaline Comet Assay. All the required chemicals
were purchased from Trevigen, Inc. (USA). The comet assay
was carried out under alkaline conditions, as described in
the attached Trevigen instructions. Cells (WI-38, HCT116
and P32T) with or without H2O2 or HAP treatment were
suspended in 1% low melting point agarose in 1xPBS, pH
7.4, at 37◦C and immediately pipetted onto a CometSlide.
The agarose was allowed to set at 4◦Cf o r1 0 −30min and the
slide was immersed in a lysis solution at 4◦Cf o r5 0m i nt o
remove cellular proteins. Slides were then placed at 0.3M
NaOH and 1mM EDTA for 45min at room temperature
before electrophoresis at 300mA for 60min at 4◦C. The
slides were then washed two times for 10min each with
water and then dehydrated in 70% ethanol for 5min before
staining with 1xSYBR Green I staining solution. To prevent
backgroundDNAdamage,handlingsamplesandallthestepsJournal of Nucleic Acids 5
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Figure 6: HAP induces DNA breaks in human cells. The eﬀect of
HAP and 100μM hydrogen peroxide on the frequency of single-
strandedbreaksrecordedattheendoftreatmentinWI-38,HCT116
and P32T cell cultures by single-cell electrophoresis at pH > 13.
(a) Analysis of the concentration-dependent eﬀects of HAP and
hydrogen peroxide on the frequency of DNA strand breaks in
WI-38, HCT116 and P32T cells. The damaging DNA-agent dose
responses are plotted on the x-axis. The mean percent DNA in the
comettailisplottedonthe y-axisasaratiooftheamountofDNAin
the comet tail/the amount of DNA in the whole comet. The insert
in the upper part of the plot is a linear plot of this correlation for
each culture. Results are shown as means±standard error of results
of six diﬀerent experiments. The level of statistical signiﬁcance was
set at P<. 05. (b) Micrographs of WI-38 (a, b, c), HCT116 (d, e,
f), and P32T (g, h, i) cells treated with diﬀerent doses of HAP: 0 (a,
d, g), 0.66mM (b, e, h) and 3.3mM (c, f, i) for 24hr. Bar—10μm.
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Figure 7: Intracellular localization and induction of ITPA. (a)
The eﬀect of HAP on ITPA levels and distribution in the WI-
38, HCT116 and P32T cells. Immunoﬂuorescence of ITPA in
the WI-38, upper row, HCT116, middle row and P32T, lower
row. Immunostaining and counterstaining were performed with
antirabbit monoclonal antibody (green) and DAPI (blue), respec-
tively. Bar—10μm Representative images are shown. (b) Details
of immunoﬂuorescence pattern of ITPA in the HAPtreated WI-38
(upper row, 1.32mMHAP) and P32T (lower row, 0.66mMHAP)
cells. Left column—DAPI only, middle column—detection of ITPA
antibodies, and right column—merged picture.
included in the preparation of the slides for the comet assay
were conducted under yellow light or in the dark.
The slides were examined using an epiﬂuorescence
microscope “Nikon Eclipse 80i.” A total of 100 comets
per slide were scored. Comets were randomly captured at
a constant depth of the gel, avoiding the edges of the
gel, occasional dead cells, and superimposed comets. The
percent (%) of DNA in the comet tail was used in this
study as the measure of DNA damage. Consistent with the
Trevigen Inc. application guide, the average content of DNA
in the comet tail of untreated normal cells is less than
ten percent. The amount of DNA in the comet tail was
estimated by computerized image analysis of selected comets
using CometScore software. Six independent experiments
were performed. Then, the average and standard error was6 Journal of Nucleic Acids
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Figure 8: HAP treatment leads to the increase of ITPA levels in
HCT116 cell extracts. Western blots were performed as described in
Section 2. Two controls are in the left part: ﬁrst lane—His-tagged
pure ITPA (30kDA), second lane:—pure ITPA (23kDa). Third,
fourth, and ﬁfth lane shows the levels of ITPA (23kDA) in extract
of untreated cells, and cells treated by 0.66mM HAP and 1.32mM
HAP. To estimate the induction of ITPA, we measured the ratio
of the intensity of the band corresponding to monomeric ITPA to
nonspeciﬁc bands. Estimated by this method, the induction relative
to the control was 2.2 times at 0.66mM and 2.6 times at 1.32mM.
determined. The statistical signiﬁcance of diﬀerences was
estimated by Student’s t-criterion.
2.4. Chromosome Analysis. For metaphase chromosome
spreads, WI-38, HCT116, and P32T cells (treated for 23h
with DMSO or HAP in DMSO) were arrested in metaphase
by a 1h treatment with 0.5μg/ml colcemide (Gibco URL,
USA), treated hypotonically with 0.075MKCl, ﬁxed three
times in a 3:1 methanol-acetic acid mixture, spread on
glass slides, and air dried. Twenty spreads for each culture
were analyzed by CytoVision software (Genetix Corp., CA);
only the total number and size of the chromosomes were
determined.
2.5. Western Blot Analysis. HCT116, WI-38, and P32T
c e l l sw e r ec u l t i v a t e du n t i ls u b c o n ﬂ u e n c e( 5 ×105 cells per
plate). The cells were harvested and resuspended in the
lysis buﬀer (1xPBS containing a protease inhibitor cocktail
(Roche Biochemicals, IN, USA), pH=7.4). Each pellet was
mechanicallyshearedusingapestle.Thelysatewasclearedby
centrifugation and protein content determined by Bradford
reagent from BioRad. The lysate equivalent to 100μgo f
protein was boiled in Laemli’s buﬀer (Invitrogen, USA). The
protein samples were resolved on a 10%−20% Tris-Glycine
gel(Invitrogen,USA)bySDS-PAGEandtransferredtonitro-
cellulose membranes. Membranes were blocked overnight
in commercially available blocking buﬀer (Thermo Sci-
entiﬁc, USA). Membranes were then incubated in 1:500
dilutions of primary antibody against ITPA (the in-house
polyclonal antibodies against ITPA are described elsewhere
[55]) and GAPDH (Cell Signaling #2118) for one hour at
room temperature. The membranes were then washed with
commercially available washing buﬀer (Thermoscientiﬁc,
USA) ﬁve times for 10min each. This was followed by
incubation with secondary antibody (1:1500 dilution) (Cell
signaling #7074) for 40min at room temperature. This was
followed by washing (5 times for 10min each) and detection
by the ECL system (ThermoScientiﬁc, USA) according to
the manufacturer’s instructions. The results are presented
in Figure 4. A major visible band, corresponding to ITPA
(compare with lane with pure ITPA), is prominent in WI-
38 ﬁbroblasts, and cancer HCT116 cell extracts (gray arrow)
but is less pronounced in P32T cells, as we described before
[55]. The intensity of the non-speciﬁc 30kDa band is similar
in all three cell lines. The position of the immunoreactive
bandwasshiftedup,closertothe30kDamarker,inlanewith
6 His-tagged pure ITPA-P32T (predicted molecular mass
23.6kDa [47]). We also analyzed the extract of 293 cell lines
transfected with a plasmid expressing the gene for ITPA-
EGFP fusion protein (51.4kDa) and have found that a major
band was detected at a position corresponding to 50kDA.
The data unequivocally prove that antibodies react primarily
with ITPA.
For the analysis of ITPA induction by HAP by Western
blots we cultivated HCT116 cells with or without HAP
until subconﬂuence (5×105 cells per plate). The cells were
harvested and resuspended in the lysis buﬀer (50mMTris,
pH=8.0, 1mM PMSF, 10% (v/v) glycerol, 0.5% Triton X-
100) and disrupted and processed as before with the fol-
lowing modiﬁcations to improve the quality and resolution.
The lysate equivalent to 30μg of protein was boiled in
Laemli’s buﬀer containing 100mM DTT and loaded on a
10%−20% Tris-Glycine gel by SDS-PAGE. After trial run
and Coomassie staining the amount of extracts was further
adjusted to produce equal amount of loaded protein in the
control and treatment and run in the new gel. After transfer,
nitrocellulose membranes were blocked overnight in 5% dry
milk/1x PBST. Membranes were incubated in 1:2000 dilu-
tions of primary antibody against ITPA described above for
onehouratroomtemperature.Themembraneswerewashed
with 1x PBST three times for 15min each, and, incubated
with secondary HRP-linked antibody (1:100000 dilution)
(Cell Signaling #7074) for 1 hour at room temperature.
Membrane was washed three times for 15min each and
signals were detected by SuperSignal West Femto Maximum
Sensitivity Substrate (ThermoScientiﬁc, USA) according to
the manufacturer’s instructions.
2.6. Immunocytochemistry. Cells (WI-38, HCT116 and
P32T) with or without HAP treatment were ﬁxed with
methanol acetic acid mixture (3:1). All procedures were
performed at room temperature. To prevent non-speciﬁc
binding in the consequent antibody detection, samples were
blocked in 1xPBS containing 5% BSA and 0.05% Tritone
X-100. We have used the primary antibodies against ITPA
described in the previous section and a goat-antirabbit
antibody Alexa Fluor 488nm conjugated (Thermoscientiﬁc,
USA). Both antibodies were diluted 1:1000 in 1xPBS con-
taining 5% BSA and 0.05% Triton X-100. Slides were washed
three times in 1xPBST buﬀer between incubations with
primary and secondary antibodies and after incubations.
After washing, the cells were counterstained with DAPI,
mounted in antifade medium and analyzed by ﬂuorescent
microscopy. No ﬂuorescence was detected when primary
antibodies were omitted from the protocol, and very low
signal was detected when preimmune rabbit serum was usedJournal of Nucleic Acids 7
in place of primary antibody, suggesting that ﬂuorescence
signals were absolutely dependent on antiITPA antibodies.
Three independent repeats of this experiment have been
done.
2.7. Microscopy and Image Analysis. After the comet assay
or immunocytochemistry procedures, cells were examined
on a Nikon Eclipse 80i microscope. Images were recorded
separately by a CCD device Photometrics CoolSnap cf and
merged using Adobe Photoshop software.
3. Results
3.1. HAP Does not Cause Chromosome Hyperfragmentation
in Three Human Cell Lines. It has been reported previously
that treatment of human epidermoid carcinoma cells with
1mMHAPleadtomassivechromosomefragmentation(Fig-
ure 2 in [66]). We examined HAP eﬀects on chromosomes in
WI-38, HCT116, and P32T lines. We studied chromosome
spreads of untreated WI-38, HCT116, and P32T cells
versus the same cells treated with 3.3mMHAP. There were
no more chromosomal abnormalities after treatment with
3.3mMHAP than in the untreated HCT116 chromosome
spreads (Figure 5). We did not observe any striking diﬀer-
ences in the rates of chromosomal abnormalities in WI-38
and P32T chromosome spreads as well (data not shown).
It is possible that the cell line used in earlier studies was
hypersensitive to HAP.
3.2. The Increase in HAP Dose Proportionally Elevated the
Rate of DNA Breaks in WI-38, HCT116, and P32T Cells.
We investigated the eﬀect of 24h treatment by diﬀerent
HAP concentrations on the frequency of single-stranded
breaks in WI-38, HCT116 and P32T cell cultures by single
cell electrophoresis at pH > 13. Under our experimental
conditions and with doses of mutagens used, no substantial
cell killing occurred. The percent of DNA in the comet tail
(thereafter named tail DNA) of the total DNA was used in
the study as the estimate of the amount of single-stranded
breaks. The mean tail DNA was statistically signiﬁcantly
diﬀerentinthethreelines:8.42%inuntreatednormalWI-38
ﬁbroblasts, 12.4% in colorectal cancer cell culture HCT116,
and the highest 17.6%, in P32T ﬁbroblast cell culture, a
large change for this type of assay two-fold increase over
normal ﬁbroblasts (Figure 6(a)). The increased level of tail
DNA in untreated cells likely indicates persistent unrepaired
endogenous damage in HCT116 and P32T cells.
WI-38 normal ﬁbroblasts were quite resistant to HAP:
thehighestconcentrationof3.3mMHAPincreasedtailDNA
two-foldto20.5%,muchlessthanthepositivecontrolhydro-
gen peroxide (42.8% tail DNA) (Figure 6(a)). The induction
curve had quite a gentle slope with a small hump/plateau
of resistance when the dose increased from 0.66 to 1.32
(seen clearly in the insert in Figure 6(a)). The comet tails in
WI-38 cells after treatment with 0.66mM−3 . 3m Mo fH A P
were the shortest among the variables studied (Figure 6(b)).
The response of the HCT116 cells to the hydrogen peroxide
treatment was similar to that of the WI-38 cells (tail DNA
was 42.9%). HAP produced more DNA damage than in
WI-38 cells. An initial eight percent increase at 0.66mM
was followed by the plateau of around 25% tail DNA at
doses 1.32mM−2.64mM (Figure 6(a), insert). This apparent
resistance to the induction of breaks was ﬁnally concurred by
3.3mM of HAP and tail DNA reached 30.3% (Figure 6(a)).
P32T cells were most sensitive to HAP, while the sensitivity
to hydrogen peroxide was similar to other cell lines (43.4%).
The lowest dose of HAP induced as much tail DNA in
P32T as the highest dose in normal ﬁbroblasts (21%). The
1.98mMHAP produced 30.7% tail DNA in P32T, exceeding
the maximum of tail DNA induced by HAP in other
cell cultures studied at the same dose. After 3.3mMHAP
treatment of these cells, the level of tail DNA reached 52.7%
and the tail was much longer than in WI-38 and HCT116
under the same conditions (Figures 6(a) and 6(b)). In
summary, HAP induced DNA breaks in human cells. HAP
was moderately active in normal WI-38 ﬁbroblasts, HCT116
cancer cells were more sensitive than WI-38 cells and P32T
ITPA-deﬁcient ﬁbroblasts were the most susceptible.
3.3. ITPA Cellular Levels and Distribution Change Diﬀerently
afterHAPTreatmentofWI-38,HCT116andP32TLines. The
presence of the plateau in the dose-response curves for HAP
indicatedthatwild-typecellsmightpossessaninduciblepro-
tection system, which is activated at 0.66−1.32mMHAP. One
possible candidate is ITPA and we studied ITPA distribution
after HAP treatment in WI-38, HCT116 and P32T cells by
whole-cell immunostaining with speciﬁc antibodies against
ITPA (speciﬁcity of antibodies has been veriﬁed by Western
Blot, because of the shift of detected GFP-tagged ITPA to
higher position, Figure 4).
ITPA was not readily detected in untreated WI-38
ﬁbroblasts, and cells were stained very weakly (Figure 7(a)).
ThedetectedITPAamountincreasedafterthetreatmentwith
0.66mM and 1.32mMHAP. The untreated HCT116 cancer
cells were stained with antibody against ITPA somewhat
more eﬃciently than WI-38 cells (Figure 7(a)). The ITPA
amount increased after 0.66mM and 1.32mMHAP treat-
ment, the latter dose producing strikingly bright cytoplasm
(Figure 7(a)). Maybe this phenomenon simply relates to the
smaller size of cytoplasm relative to nucleus. Some ITPA
was detected in untreated ITPA-deﬁcient P32T ﬁbroblasts,
similar to HCT116 cells (Figure 7(a), lower row). After
treatment with 0.66mMHAP, the ITPA amount increased,
so induction occurred at lower dose.
Fluorescence in all cases was mostly in cytoplasm and
was generally uneven. The brighter ﬂuorescent regions in
WI-38 cells were of three types. One type resembled a net
structureadjacent to nuclei. Another type was small granules
localized in nuclei (Figure 7(b), upper row). The third was
one big bright granule, typically at the border of nuclei and
cytoplasm or localized in the nuclei close to its edge. In
HCT116, the heterogeneity was less pronounced and the net
structure was not observed (compare to Figure 7(a)). It is
possible that it is undetectable due to a small cytoplasmic
part of the cell and very bright ﬂuorescence. In P32T
ﬁbroblasts the distribution was diﬀerent. Net-like structure
has not been observed. Some brighter regions adjacent to8 Journal of Nucleic Acids
nuclei were present but they were unstructured (Figure 7(b),
lower row).
We also have used Western blot analysis in HCT116
cells to conﬁrm and quantify induction of ITPA by HAP
(Figure 8). Clearly, HAP treatment leads to up to 2.6-fold
elevation of the amount of ITPA.
4. Discussion
4.1. Response of Human Cells to Base-analog HAP Treat-
ment. It is known that HAP is mutagenic, clastogenic and
carcinogenic in hamster cells [67, 68]. Using Comet assay
we have shown that HAP produced DNA breaks in the
human cell lines tested. The most logical explanation of
this and other currently available data is that the base-
analog was incorporated into DNA and either human Endo
V homolog (encoded by the LOC284131, see description of
closelyrelatedmousehomologin[51])orotheranunknown
glycosylase/endonuclease recognized incorporated HAP and
incised DNA strands (Figure 1).
Analysis of the dose-response curves revealed a
hump/plateau region indicative of the induction of a
cellular protective response/repair system. The HAPtreated
WI-38 ﬁbroblasts with wild-type ITPA had the lowest rates
of DNA breaks, and untreated WI-38 cells had the lowest
levels of spontaneous breaks among cell lines studied. The
hump in the dose-response curve indicated that there is an
induction of the repair activity at 0.66−1.32mMHAP.
We found moderately elevated levels of spontaneous
breaks in HCT116. It remains to be determined whether this
eﬀect is related to the defect of a mismatch-repair system.
The levels of DNA breaks by HAP in HCT116 cells were
higher than in WI-38 ﬁbroblasts and the analysis of the dose-
response curve indicated that the repair system most likely
was activated completely only by 1.32mMHAP.
The P32T ITPA-deﬁcient ﬁbroblasts were the most
sensitive to the induction of DNA breaks by HAP treatment.
We propose that deoxyribonucleoside triphosphates of HAP,
usually removed by ITPA in wild-type cell lines, remain in
the detectable amount in the DNA precursor pools of ITPA
P32T ﬁbroblasts. They are incorporated in DNA causing the
excess of DNA breaks. This observation correlates well with
the accumulation of ITP only in this cell line (Figure 3).
It is known that ITPA P32T produced ectopically protects
bacteria and yeast from HAP to the same extent as wild-
type ITPA, but the level of ITPA P32T in human cell
extracts is much lower than in normal ﬁbroblasts [62].
Apparently, the human repair system does not work properly
in P32T cells alleviating DNA damage by downstream repair
enzymes. The spontaneous level of DNA breaks in this
cell line was the highest, raising the possibility that there
is persistent endogenous DNA damage in these cells. It
is tempting to speculate that the damage is caused by
endogeous dITP/dXTP.
The next set of experiments explored one possible
component of the HAPinduced repair system.
4.2. ITPA Levels and Distribution in HAP Treated Human
Cells. We have analyzed in detail the levels and intracellular
distribution of ITPA. We conﬁrmed that the enzyme is
located mainly in cytoplasm [69]. We have found that
ITPA levels increased signiﬁcantly upon treatment with HAP
in all the investigated cells, although it was signiﬁcantly
lower in the ITPA P32T ﬁbroblasts than in WI-38 and
HCT116 cells. P32T ITPA-deﬁcient ﬁbroblasts responded by
theproductionofITPAtomuchlowerdosesofHAP,because
the destruction of HAPTP is less eﬃcient in these cells and
eﬀective concentrations of substrates for the ITPA are higher.
The antibody staining revealed a net-like structure
adjacent to nuclei and other, granular structures in the
WI-38 normal ﬁbroblasts, when ITPA is induced by HAP.
This is consistent with previous analyses of the localization
of ITPA to purine biosynthetic complexes. It has been
shown previously that human enzymes involved in de novo
purine biosynthesis (for example, hTrifGART protein, and
formylglycinamidine ribonucleotide synthase, PRPP ami-
dotransferase, hPAICS, adenylosuccinate lyase and hATIC),
colocalize and cluster in human cell cytoplasm [70]. This
is consistent with the hypothesis that these clusters rep-
resent a “purinosome”—an organoid essential for purine
biosynthesis. Usually these clusters localized throughout
the whole cytoplasm volume but there were one or two
big clusters on the border of nuclei and cytoplasm. One
possible interpretation of our results is that ITPA, the
enzyme of purine “salvage” pathway, constitutes a part of
this purinosome. The candidate structure is a big ﬂuorescent
granule. Further colocalization experiments are needed to
test our hypothesis.
Hypothetically, the net-like structure described here may
represent a factory checking quality of dNTP pools. It is
possible that this abnormal ITPA distribution is one of the
reasons for a lack of ITPA function in P32T individuals,
despite almost normal activity of the enzyme [62].
Taken together, our results suggest that human cells
possess a repair system for purine base-analogs similar, in
part, to bacteria. The genetically active derivative of HAP
is deoxyribonucleoside triphosphate. Cells are protected
from dHAPTP by hydrolysis by ITPA. Some dHAPTP is
presumably incorporated into DNA, and subsequent repair
of HAP leads to DNA strand breaks.
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